| Authors: |
Oller A; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kemmeren P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Center for Molecular Medicine, UMC Utrecht and Utrecht University, Utrecht, the Netherlands., Perotti D; Predictive Medicine: Molecular Bases of Genetic Risk, Experimental Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy., van Tinteren H; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Verschuur A; Department of Pediatric Haematology-Oncology, La Timone Children's Hospital, AP-HM, Marseille, France., Spreafico F; Paediatric Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.; Oncology Unit, IRCCS Istituto Giannina Gaslini, Genoa, Italy., Brok J; Department of Paediatric Oncology and Haematology, Rigshospitalet, Copenhagen, Denmark., Furtwängler RCJ; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Inselspital University Hospital, University of Bern, Bern, Switzerland.; Department of Pediatric Hematology and Oncology, Saarland University, Homburg, Saarland, Germany., Chowdhury T; Department of Pediatric Oncology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom., Al-Saadi R; Developmental Biology and Cancer Research and Teaching Department, UCL Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.; Department of Histopathology, Great Ormond Street Hospital for Children, London, United Kingdom., Vujanic GM; Department of Pathology, Sidra Medicine, Doha, Qatar., Treece AL; Department of Pathology and Laboratory Medicine, Children's of Alabama, Birmingham, AL., Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands.; Division Cell Biology, Metabolism & Cancer, Department Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands., van Grotel M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Mullen EA; Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Harvard Medical School, Boston, MA., Evageliou NF; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Graf N; Department of Pediatric Hematology and Oncology, Saarland University, Homburg, Saarland, Germany., Hong AL; Department of Pediatrics, Emory University School of Medicine, Atlanta, GA.; Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA., Gessler M; Developmental Biochemistry, Theodor-Boveri-Institute/Biocenter, Julius-Maximilians-University Wuerzburg, Würzburg, Germany.; Comprehensive Cancer Center Mainfranken, University Hospital of Würzburg, Würzburg, Germany., Geller JI; Peckham Center for Cancer and Blood Disorders, Rady Children's Hospital, San Diego, CA.; Division of Pediatric Hematology/Oncology, Department of Pediatrics, University of California San Diego, La Jolla, CA., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Division of Child Health, University Medical Center Utrecht-Wilhelmina Children's Hospital, Utrecht, the Netherlands. |
